Drug Eluting Balloon Market will grow at highest pace owing to rising cardiovascular diseases

Drug-eluting balloons (DEBs) are advanced medical devices designed for percutaneous transluminal angioplasty that deliver anti-restenotic drugs directly to arterial walls during balloon inflation.
Combining the mechanical benefits of balloon angioplasty with targeted pharmacological therapy, DEBs help prevent neointimal hyperplasia and reduce the risk of vessel re-narrowing. These devices offer advantages over traditional drug-eluting stents, including reduced dependency on long-term dual antiplatelet therapy and lower rates of late stent thrombosis.

Get more insights on Drug Eluting Balloon Market - https://www.coherentmarket...

#DrugElutingBalloonMarketDemand
#DrugElutingBalloonMarketGrowth
#DrugElutingBalloonMarketTrend
#CoherentMarketInsights